The combined serum levels of<i>miR-375</i>and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancerSven Wach, Helge Täubert, Katrin Weigelt et al.|International Journal of Cancer|2015Cited by 53